Somatrogon for treating growth disturbance in children and young people aged 3 and over: Cost comparison evaluation for the National Institute for Health and Care Excellence

Research output: Book/ReportCommissioned report

Original languageEnglish
PublisherNational Institute for Health and Care Excellence
Commissioning bodyNational Institute for Health Research (NIHR)
Publication statusPublished - 2022

Cite this